Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
US Army
Cipla
Covington
Healthtrust
Fuji
McKesson
Mallinckrodt
US Department of Justice
Teva

Generated: October 23, 2017

DrugPatentWatch Database Preview

Bendroflumethiazide - Generic Drug Details

« Back to Dashboard

What are the generic sources for bendroflumethiazide and what is the scope of bendroflumethiazide patent protection?

Bendroflumethiazide
is the generic ingredient in five branded drugs marketed by Apothecon, Impax Labs, King Pharms Llc, and Mylan, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for bendroflumethiazide.

Summary for Generic Name: bendroflumethiazide

US Patents:0
Tradenames:5
Applicants:4
NDAs:4
Drug Master File Entries: see list4
Bulk Api Vendors: see list34
Clinical Trials: see list3
Patent Applications: see list4,843
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:bendroflumethiazide at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms Llc
CORZIDE
bendroflumethiazide; nadolol
TABLET;ORAL018647-002May 25, 1983ABRXYesYes► Subscribe► Subscribe► Subscribe
Apothecon
NATURETIN-5
bendroflumethiazide
TABLET;ORAL012164-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
NADOLOL AND BENDROFLUMETHIAZIDE
bendroflumethiazide; nadolol
TABLET;ORAL078688-001Feb 15, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Labs
NADOLOL AND BENDROFLUMETHIAZIDE
bendroflumethiazide; nadolol
TABLET;ORAL077833-002Mar 30, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Labs
NADOLOL AND BENDROFLUMETHIAZIDE
bendroflumethiazide; nadolol
TABLET;ORAL077833-001Mar 30, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Apothecon
NATURETIN-2.5
bendroflumethiazide
TABLET;ORAL012164-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
King Pharms Llc
CORZIDE
bendroflumethiazide; nadolol
TABLET;ORAL018647-001May 25, 1983ABRXYesNo► Subscribe► Subscribe► Subscribe
Mylan
NADOLOL AND BENDROFLUMETHIAZIDE
bendroflumethiazide; nadolol
TABLET;ORAL078688-002Feb 15, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Apothecon
NATURETIN-10
bendroflumethiazide
TABLET;ORAL012164-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Colorcon
Citi
McKinsey
Dow
Harvard Business School
Express Scripts
Daiichi Sankyo
Julphar
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot